SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,192,000 | -24.7% | 281,702 | -4.5% | 0.46% | -1.5% |
| Q3 2021 | $5,569,000 | +1.6% | 294,825 | 0.0% | 0.47% | +26.1% |
| Q2 2021 | $5,481,000 | -18.3% | 294,825 | 0.0% | 0.37% | -28.0% |
| Q1 2021 | $6,710,000 | +53.3% | 294,825 | +46.2% | 0.52% | +32.7% |
| Q4 2020 | $4,377,000 | +14.0% | 201,600 | -52.3% | 0.39% | -34.6% |
| Q3 2019 | $3,841,000 | -24.3% | 422,589 | -5.2% | 0.59% | -14.6% |
| Q2 2019 | $5,074,000 | +1.7% | 445,889 | +1.8% | 0.69% | +52.5% |
| Q1 2019 | $4,988,000 | +35.6% | 437,889 | +7.4% | 0.46% | +9.6% |
| Q4 2018 | $3,679,000 | -10.8% | 407,889 | +48.3% | 0.42% | -12.4% |
| Q3 2018 | $4,125,000 | – | 275,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |